Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Middlebury. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Middlebury at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
This is a multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the efficacy of vadadustat administered three times a week compared to standard of care erythropoiesis-stimulating agent for the treatment of anemia in in-center hemodialysis participants with end-stage kidney disease (ESKD). A subset of sites will participate in a red blood cell (RBC) sub-study where changes in the phenotype of RBCs in response to vadadustat treatment relative to methoxy polyethylene gly
Sponsor: Akebia Therapeutics
Check if you qualify for this chronic kidney disease clinical trial in Middlebury, CT
If you're searching for chronic kidney disease treatment options in Middlebury, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Middlebury research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.